October 12, 2016
Nordic Nanovector ASA: Extraordinary General Meeting held
Media
October 12, 2016
Nordic Nanovector announces the appointment of Joanna Horobin, MD, as Non-executive Board Director
October 10, 2016
Aprea Therapeutics Announces First Patients Enrolled in Phase II Clinical Study of APR-246 for the Treatment of High-Grade Serous Ovarian Cancer
October 10, 2016
Aprea Therapeutics Announces Efficacy and Safety Data in High-Grade Serous Ovarian Cancer Patients Treated with APR-246 in Presentation at 2016 European Society for Medical Oncology (ESMO) Annual Meeting
October 10, 2016
Nordic Nanovector and LegoChem Biosciences enter collaboration to develop novel antibody-drug conjugates (ADCs) targeting leukaemias
October 10, 2016
Onxeo to Present at the 15th Annual BIO Investor Forum in San Francisco
October 04, 2016
Mundipharma and Orexo announce EU regulatory submission for Zubsolv®
October 03, 2016
Strongbridge Biopharma plc Announces Appointment of Jeffrey W. Sherman, M.D., FACP, to Board of Directors
September 30, 2016
Onxeo Raises €12.5 Million through Capital Increase with US and European Investors
September 28, 2016
HealthCap makes 104th investment as Swedish company Oncorena secures SEK 24m financing